Urinary leukotrience E(4) level in children with asthma.
- Author:
Mei-Juan HE
1
;
Qiang CHEN
;
Jian-Mei LIU
Author Information
- Publication Type:Journal Article
- MeSH: Airway Resistance; Asthma; diagnosis; physiopathology; urine; Child, Preschool; Enzyme-Linked Immunosorbent Assay; Female; Humans; Infant; Leukotriene E4; urine; Male
- From: Chinese Journal of Contemporary Pediatrics 2009;11(11):909-912
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVECysteinyl leukotriene (CysLTs) plays an important role in airway inflammation and remodeling in asthma. Measurement of urinary leukotriene E(4) (LTE(4)) is a sensitive and noninvasive method of assaying total body CysLTs level. This study aimed to evaluate the clinical significance of urinary leukotriene E(4) (LTE(4)) in childhood asthma.
METHODSSixty children with acute asthma were randomly divided into montelukast (leukotriene receptor antagonist) treatment and conventional treatment groups (n = 30 each). Urinary LTE(4) levels were measured using ELISA and the airway resistance Rint was assessed by the lung function instrument at the acute and the convalescence phases. Twenty healthy children were used as the control group.
RESULTSUrinary LTE(4) levels in asthmatic children at the acute and the convalescence phases were significantly higher than those in the control group (p<0.01). The urinary LTE(4) levels at the convalescence phase were significantly reduced compared with those at the acute phase in asthmatic children (p<0.01). More significantly decreased urinary LTE(4) levels were noted in the montelukast treatment group than the conventional treatment group at the convalescence phase (p<0.01). In the acute phase, there was no correlation between urinary LTE4 level and Rint in asthmatic children.
CONCLUSIONSUrinary LTE(4) level is significantly increased in children with acute asthma. Urinary LTE(4) is a useful marker for the diagnosis of asthma and can be as a predictor of asthma control and marker of susceptibility to treatment with leukotriene receptor antagonists.